Pelican Products, Inc., the leader in the design and manufacture of  high-performance protective case solutions and advanced portable lighting systems, today announced the acquisition of Minnesota Thermal Science (MTS), the industry leader in global temperature controlled transportation products. Based in Plymouth, Minnesota, MTS will merge with Pelican’s already established BioPharma™ division.
    
“The combined entity will offer customers an even wider range of the most advanced temperature controlled packaging solutions for the safe transport of pharmaceuticals, tissue, biologics, diagnostics, blood and other healthcare products,” said Lyndon Faulkner, President and CEO of Pelican. “The award-winning thermal protection products of MTS will be matched with Pelican’s global capabilities providing a worldwide solution of re-usable transportation and packaging products and services.”
    
In addition to Pelican BioPharma cases that offer 140+ hours between 2.0 to 8.0C, customers will have access to the full suite of MTS products including the reusable Credo Cube®, which protects payload contents at defined temperatures longer than any other passive thermal shipper.  Equally impressive are the Credo Xtreme® full pallet which holds 890 liters and the half pallet which holds 406 liters, each providing 35% more payload space than the closest competitor.  In addition to their unique scientific packaging, MTS offers a complete range of services and software to support a reusable temperature controlled packaging solution.
 
“Joining forces with Pelican will enable us to aim even higher and provide customers with an unmatched global cold chain solution under one company”, said Tom Anderson, CEO of MTS. “We’re confident that together we’ll deliver products and services to the industry better than any competitive offering.  An accelerated product development program which will significantly enhance the combined company’s solution set and associated cold chain services is already underway.”

Pelican Products, Inc. is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.